Q1 2026 完成约 $245 million 投资,blended stabilized yield 为 8.8%;其中锚定 Mid-Atlantic 六处 skilled nursing 组合售后回租,收益率约 9%,并包含 UK care home 投资和一笔小型关系型贷款。(prepared)
自 4 月以来完成 12 笔交易,约 $865 million,blended stabilized yield 约 8.9%;5 月 1 日完成其中 3 笔尚未公告交易,包含第二笔 SHOP 投资,SHOP 组合达到 4 个社区。(CEO)(prepared)
年初至今完成约 $1.1 billion 投资,blended stabilized yield 约 8.9%;其中约 $705 million 为美国 skilled nursing 或 senior housing triple-net,约 $225 million 为美国贷款(主要抵押为 skilled nursing facilities),约 $160 million 为 UK care homes,其余为 SHOP。(prepared)
当前投资 pipeline 约 $360 million;其中 UK care homes 占一半以上,约 20% 为 SHOP,其余为 triple-net(skilled nursing 与 seniors housing)及少量贷款活动。(prepared)
stabilized triple-net 组合 EBITDAR rent coverage 为 2.25x,EBITDARM coverage 为 2.79x;Q1 收取 100% contractual rent and interest。(CEO)
Q1 normalized FFO 同比增长 38% 至 $107.4 million;normalized FAD 同比增长 33% 至 $107.6 million。(CFO)
每股 normalized FFO 为 $0.48,同比增长 14%;每股 normalized FAD 为 $0.48,同比增长 12%。(CFO)
Q1 通过 ATM forward program 结算 $129.5 million gross proceeds;截至 5 月 7 日,$1.2 billion unsecured revolving credit facility 已提取 $350 million,现金约 $70 million;2028 年前无 scheduled debt maturities。(CFO)
季末 net debt to annualized normalized run-rate EBITDA 为 0.6x,net debt to enterprise value 约 3.6%;流动性包括约 $70 million 现金、$850 million revolver availability、约 $879 million ATM capacity。(CFO)
股息上调 16.4%;Moody’s 将公司上调至投资级;管理层称 2026 FFO/share 指引中点较 2025 高 14.8%。(CEO)
Official guidance:2026 全年 normalized FAD/股 $1.98–$2.02;更新后的 normalized FFO 与 FAD 指引中点分别较 2025 年高 14.8% 和 13.6%,较 2026 年 2 月初次指引区间高 4.9% 和 3.9%;基于加权平均稀释股数 234 million;假设包括年内不再新增 YTD 以外投资/贷款/处置、不再新增 YTD 以外债务/股权发行、长期 triple-net 租约 2.5% 通胀型租金递增、年内剩余时间 $145 million 贷款全额偿还、英镑兑美元即期汇率无重大变化。(CFO)
Mgmt quotes
| Metric | Value | Speaker/Context |
|---|---|---|
| Q1 2026 investments closed | ~$245M;blended stabilized yield 8.8% | James B. Callister (prepared) |
| Post-Q1 transactions since April | 12 deals;~$865M;blended stabilized yield ~8.9% | James B. Callister (prepared) |
| YTD investments closed | ~$1.1B;blended stabilized yield ~8.9% | James B. Callister (prepared) |
| Investment pipeline | ~$360M | James B. Callister (prepared) |
| Stabilized triple-net EBITDAR coverage | 2.25x | David M. Sedgwick (CEO) |
| Stabilized triple-net EBITDARM coverage | 2.79x | David M. Sedgwick (CEO) |
| Q1 normalized FFO | $107.4M;+38% YoY | Derek J. Bunker (CFO) |
| Q1 normalized FAD | $107.6M;+33% YoY | Derek J. Bunker (CFO) |
| Normalized FFO/share | $0.48;+14% YoY | Derek J. Bunker (CFO) |
| Normalized FAD/share | $0.48;+12% YoY | Derek J. Bunker (CFO) |
| Q1 ATM forward settlements | $129.5M gross proceeds | Derek J. Bunker (CFO) |
| Revolver drawn / facility | $350M / $1.2B | Derek J. Bunker (CFO) |
| Cash on hand (May 7) | ~$70M | Derek J. Bunker (CFO) |
| Net debt / annualized normalized run-rate EBITDA | 0.6x | Derek J. Bunker (CFO) |
| Net debt / enterprise value | ~3.6% | Derek J. Bunker (CFO) |
| FY2026 normalized FAD/share guidance | $1.98–$2.02 | Derek J. Bunker (CFO) |
| Weighted average diluted shares assumption | 234M | Derek J. Bunker (CFO) |